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Introduction
Insertion of transmembrane proteins into biological membranes 
generally requires the activity of protein-conducting channels 
that affect translocation of the exoplasmic polar domains and 
integration into the bilayer of the membrane-spanning segments 
of the nascent membrane protein (Rehling et al., 2004; Osborne 
et al., 2005). Because the translocation channels themselves are 
membrane embedded, one might expect them to rely on copies 
of themselves for proper integration, and this indeed seems to 
be the case for the core translocation channels of the outer 
  mitochondrial membrane (TOM40; Rapaport and Neupert, 1999) 
and of the ER (Sec61α; Knight and High, 1998). Such a depen-
dency of each newly synthesized component of a given translo-
cation complex on functionally integrated copies of the same 
translocator may underlie the fi  delity of the process of mem-
brane expansion, by which each membrane serves as a template 
for its own growth. However, it also poses an evolutionary 
problem: how did biological membranes initially assemble the 
minimal membrane-integrated machinery required to permit the 
insertion of vital functional protein components? One possibil-
ity is that primitive membrane proteins can insert into lipid bi-
layers without assistance from protein-conducting channels. In 
support of this notion, a few proteins with short exoplasmic do-
mains have been shown to be capable of transmembrane inte-
gration into protein-free lipid bilayers (van Dalen and de Kruijff, 
2004; Brambillasca et al., 2005). We refer to this type of inte-
gration as unassisted, meaning that the insertion does not re-
quire membrane proteins whether or not cytosolic chaperones 
are involved in maintaining the substrate protein in a conforma-
tion competent for integration.
Although most of the investigated proteins capable of un-
assisted integration are prokaryotic (van Dalen and de Kruijff, 
2004), at least one eukaryotic protein, the ER form of cyto-
chrome b(5) (b5), inserts very effi  ciently with transmembrane 
topology into protein-free liposomes, provided that these have 
low cholesterol content (Brambillasca et al., 2005). b5 is a 
member of the group of C-tail–anchored (TA) proteins. Proteins 
of this diverse group play a variety of fundamental roles in 
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lthough transmembrane proteins generally re-
quire membrane-embedded machinery for inte-
gration, a few can insert spontaneously into 
liposomes. Previously, we established that the tail-
  anchored (TA) protein cytochrome b(5) (b5) can post-
translationally translocate 28 residues downstream to its 
transmembrane domain (TMD) across protein-free bilayers 
(Brambillasca, S., M. Yabal, P. Sofﬁ  entini, S. Stefanovic, 
M. Makarow, R.S. Hegde, and N. Borgese. 2005. EMBO J. 
24:2533–2542). In the present study, we investigated 
the limits of this unassisted translocation and report that 
surprisingly long (85 residues) domains of different 
  sequence and charge placed downstream of b5’s TMD 
can posttranslationally translocate into mammalian micro-
somes and liposomes at nanomolar nucleotide concentra-
tions. Furthermore, integration of these constructs occurred 
in vivo in translocon-defective yeast strains. Unassisted 
translocation was not unique to b5 but was also observed 
for another TA protein (protein tyrosine phosphatase 1B) 
whose TMD, like the one of b5, is only moderately hydro-
phobic. In contrast, more hydrophobic TMDs, like synap-
tobrevin’s, were incapable of supporting unassisted 
integration, possibly because of their tendency to aggre-
gate in aqueous solution. Our data resolve long-standing 
discrepancies on TA protein insertion and are relevant to 
membrane evolution, biogenesis, and physiology.
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membrane biogenesis and traffi  cking and are characterized by 
the presence of an N-terminal cytosolic region and of a single 
transmembrane domain (TMD) very close to the C terminus 
(Borgese et al., 2003). To qualify as a true TA protein, the 
C-  terminal polar domain, which is downstream of the TMD, 
must not exceed 25–30 residues so that during synthesis, the hydro-
phobic TMD is not exposed to the cytosol until the polypeptide 
is terminated and released from the ribosome. Therefore, the 
nascent polypeptide does not have a chance to interact with sig-
nal recognition particle (SRP), which mediates cotranslational 
integration, and insertion into the bilayer must occur posttrans-
lationally. In single-spanning proteins with longer C-terminal 
polar domains, the TMD becomes available to SRP while still in 
the nascent chain; these proteins can be cotranslationally inte-
grated into the ER membrane, thus qualifying as bona fi  de type 
II proteins (Borgese et al., 2003).
In our previous work, unassisted transbilayer integration 
was demonstrated for a b5 construct tagged at its C terminus 
with a 19-residue sequence derived from the N terminus of bo-
vine opsin, which provides an N-glycosylation consensus site as 
well as an epitope (Brambillasca et al., 2005). The addition of 
this tag brought the length of the C-terminal polar domain to 28 
residues, allowing us to monitor its translocation by a protease 
protection assay (Brambillasca et al., 2005). In the present 
study, we have investigated the limit of the length of the 
C-terminal polar domain appended to b5’s TMD that can be trans-
located across protein-free lipid bilayers. Although it is clear 
that further lengthening of the C-terminal polar domain will 
  result in a type II protein that can potentially use the SRP-
  dependent cotranslational Sec61-based pathway, our question is 
focused on the possible existence of an alternative overlapping, 
unassisted posttranslational pathway. Using in vitro and in vivo 
approaches in the mammalian and yeast systems, we show that 
the TMD of b5 can support the unassisted translocation of 
  surprisingly long and differently charged C-terminal polar 
  sequences with low or no energy requirements.
Although posttranslational integration is a hallmark of TA 
protein biogenesis, different TA proteins appear to have differ-
ent requirements for membrane integration. Thus, although b5 
undergoes unassisted transbilayer integration, the v-SNARE 
synaptobrevin 2 (Syb2) requires energy and a proteinaceous 
factor or factors of the ER membrane (Kutay et al., 1995; Kim 
et al., 1997; Abell et al., 2004; High and Abell, 2004). Because 
the unassisted translocation that we observed for our b5 con-
structs appeared to be relatively insensitive to the sequence of 
the lumenal domain, we investigated whether differences in the 
TMD underlie the different requirements for TA protein inte-
gration. We fi  nd that replacement of the b5 TMD with the more 
hydrophobic one of Syb2 or simply an increase in the hydro-
phobicity of b5’s TMD obtained by a few amino acid substitu-
tions results in constructs that show the same requirements for 
energy and for an ER proteinaceous component as native Syb. 
Conversely, a construct carrying a mutated Syb2 TMD with re-
duced hydrophobicity as well as the TA protein tyrosine phos-
phatase 1B (PTP1B), whose TMD, like the one of b5, is only 
moderately hydrophobic, inserts into lipid bilayers without as-
sistance. Our results suggest a mechanism by which primitive 
membranes may have assembled in the absence of modern 
translocation machinery and identify TMD hydrophobicity as 
the feature that determines the different requirements for trans-
membrane integration of TA proteins.
Results
Size limits for the posttranslational 
translocation of polar domains appended 
to b5’s C terminus
In previous studies (Pedrazzini et al., 2000; Borgese et al., 2001; 
Yabal et al., 2003; Brambillasca et al., 2005), we demonstrated 
the posttranslational transmembrane integration into ER mem-
branes of a b5 variant engineered to contain an N-glycosylation 
site (derived from bovine opsin) near the C terminus (Pedrazzini 
et al., 2000; and here renamed b5-ops-28). To investigate 
whether longer C-terminal polar domains can also be trans-
located in the posttranslational mode, we generated a battery 
of b5 constructs in which the C-terminal domain was progres-
sively elongated to 125 amino acid residues. These constructs 
were obtained by fusing unrelated oligopeptides (derived from 
the N-terminal domain of bovine opsin, from the yeast protein 
Hsp150, or from the cytosolic domain of vesicular stomatitis vi-
rus glycoprotein [VSVG]) downstream of the original construct, 
b5-ops-28, or immediately after b5’s TMD. The constructs were 
Figure 1.  Schematic representation of the constructs used in this study. 
The opsin tag (corresponding to the ﬁ  rst 19 amino acids of the bovine 
  protein) is shown as an open box, with the N-glycosylation site represented 
by a hexagon. The numbers in the name of each construct indicate the total 
length of the lumenal sequence. Sequences deriving from b5 are depicted 
in black, those from PTP1B are depicted as striped boxes, and those from 
the cytoplasmic tail of VSVG are in light gray. The shaded gray box in 
panel b indicates sequences of different lengths deriving from bovine opsin 
or yeast Hsp150. b5-ops-47 carries the entire N-terminal lumenal sequence 
of bovine opsin, which has been duplicated and triplicated in b5-ops-85 
and -125, respectively; Hsp-elongated constructs contain one, two, or four 
copies of a 19-residue repeated sequence of the yeast protein Hsp150. 
The constructs illustrated in panels a–d all have the TMD of b5; the con-
structs illustrated in panel e have an altered TMD. In b5-HH-ops-28, b5’s 
TMD has been mutated to be more hydrophobic, and in b5-scrambled-ops-28, 
the order of amino acids in b5’s TMD has been changed. In b5-Syb2-
  ops-28 and b5-Syb2mut-ops-28, it has been replaced by the one of Syb2 
or by a mutated, less hydrophobic version thereof. The TMDs of b5 (a–d), 
PTP1B (f), and Syb2 or mutated TMDs of Syb2 and b5 (e) are indicated 
with different symbols. Sequences of the TMDs and lumenal domains are 
given in Tables I and S1 (available at http://www.jcb.org/cgi/content/
full/jcb.200608101/DC1), respectively.UNASSISTED TRANSLOCATION ACROSS LIPID BILAYERS • BRAMBILLASCA ET AL. 769
named   according to the origin of the appended sequence and 
to the length of the entire C-terminal sequence downstream of 
the TMD (Fig. 1, a–d; and sequences in Table S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200608101/DC1). For 
these extended constructs, beyond a certain length of the at-
tached sequence, we might expect a shift to the cotranslational 
SRP-dependent mechanism of translocation because the TMD 
will emerge from the ribosome before chain termination and be 
recruited via SRP to the Sec61 translocon, as occurs with clas-
sic type II membrane proteins (Fig. 2 A). 
To compare posttranslational and cotranslational translo-
cation effi  ciencies, ER rough microsomes (RMs) were either 
added during translation of the various constructs or after the 
termination of protein synthesis and removal of ribosomes (Fig. 2). 
To follow translocation, we used our previously developed 
stringent assays (Brambillasca et al., 2005), which are based 
both on the Mr shift caused by N-glycosylation of the translo-
cated opsin sequence and on protection from protease K (PK) 
digestion of the translocated fragment. An aliquot of each sam-
ple was directly analyzed by SDS-PAGE to determine the 
amount of protein synthesized and the extent of glycosylation 
(Fig. 2, B and C; top, −PK), whereas the rest was digested with 
PK and subjected to immunoprecipitation to recover the pro-
tected fragment (PF; Fig. 2, B and C; bottom, +PK; see 
  Brambillasca et al., 2005 for a full characterization of the assay).
As shown in Fig. 2 (B and C), when the constructs were 
not exposed to RMs, only the nonglycosylated protein was de-
tected (boxes indicate the nonglycosylated full-length protein or 
PF). Likewise, PFs were not recovered from samples incubated 
in the absence of membranes nor from samples incubated with 
membranes but digested with PK in the presence of detergent 
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/
jcb.200608101/DC1). Instead, when RMs were present either 
during or after translation, a portion of each construct with lu-
menal domain up to 85 residues was converted to the glycosyl-
ated form (Fig. 2, B and C; asterisks indicate the glycosylated 
full-length protein or PF) except the construct b5-VSVG-33, 
which lacks an N-glycosylation consensus sequence (Fig. 2 C). 
In agreement, these constructs, after co- or posttranslational 
incubation with RMs followed by PK treatment in the absence 
of detergent, generated a PF, most of which was glycosylated 
(again, with the exception of b5-VSVG-33). In contrast, the 
constructs bearing a sequence longer than 100 amino acids 
downstream of the TMD, although capable of cotranslational 
translocation, were no longer able to insert posttranslationally, 
as indicated by the lack of glycosylation and protection from 
proteolysis (Fig. 2 B, compare lane 14 with 15 and lane 17 
with 18).
Quantitative comparison of co- and posttranslational 
translocation (Fig. 2 D) revealed equal effi  ciencies for the 
Figure 2.  Comparison between co- and posttranslational 
translocation efﬁ  ciencies for b5 constructs with extended lu-
menal domains. (A) Illustration of the different hypothetical 
modes of insertion into RMs for the constructs in this study. The 
thickened part of the polypeptide chain represents the hydro-
phobic membrane-anchoring segment (see Results for further 
explanation). (B) b5-based constructs were incubated with or 
without RMs after (post) in vitro translation or with RMs during 
translation (co) as indicated. An aliquot of each sample was 
directly subjected to SDS-PAGE (top; −PK), whereas the re-
maining was digested with PK (bottom; +PK). (C) Co- or post-
translational translocation reactions for VSVG-elongated 
constructs. (B and C) Asterisks indicate the glycosylated form 
of both the full-length proteins (−PK) and the PFs (+PK), 
whereas the boxes indicate the corresponding nonglycosyl-
ated forms. For each construct, the total number of charged 
amino acids and the net charge of the lumenal sequence are 
reported in parentheses above the lanes. (D) Comparison be-
tween efﬁ  ciencies of post- versus cotranslational translocation 
for the constructs illustrated in B and C (see Materials 
and methods).JCB • VOLUME 175 • NUMBER 5 • 2006  770
  constructs with C-terminal polar domains of up to 66 residues, 
whereas the construct with 85 lumenal residues showed slightly 
reduced effi  ciency, and those with >100 residues showed se-
verely reduced effi  ciency in the post- versus the cotranslational 
mode. Thus, remarkably large domains of different sequence 
and net charge (Fig. 2, B and C; indicated above the lanes) are 
capable of posttranslational translocation. Interestingly, as pre-
viously shown for b5-ops-28 (Brambillasca et al., 2005), only 
the C terminus and not the N terminus of the recombinant pro-
teins was translocated, as demonstrated by the lack of protection 
of b5’s catalytic domain from PK digestion (unpublished data).
In a previous study, we showed that the transmembrane 
integration of b5-ops-28 occurs effi  ciently in yeast mutants that 
are defective in the function of the translocon or translocon 
  accessory proteins (Yabal et al., 2003). In this study, we investi-
gated whether the extended constructs could also translocate 
their C terminus across the ER of yeast sec61 mutants. As shown 
in Fig. 3, in the temperature-sensitive sec61-3 mutant, all of the 
analyzed recombinant proteins were fully or nearly fully glyco-
sylated at the restrictive temperature, as indicated by the shift in 
electrophoretic mobility obtained after digestion with endogly-
cosidase H. In contrast, the glycosylation of carboxypeptidase 
Y (CPY), a protein that depends on the Sec machinery for its 
posttranslational translocation, was severely reduced at the re-
strictive temperature (Fig. 3, bottom), demonstrating inactiva-
tion of the mutant Sec61 protein by heat treatment. Similar 
results were obtained with another temperature-sensitive Sec61p 
mutant, sec61-2 (Table S2, available at http://www.jcb.org/cgi/
content/full/jcb.200608101/DC1; and not depicted). Thus, 
Sec61-independent translocation in vivo appeared to be even 
more permissive than posttranslational translocation in vitro 
  because even the b5-ops-125 construct was glycosylated in 
the yeast mutants.
Unassisted transmembrane 
integration of extended constructs 
into protein-free liposomes
In a previous study (Brambillasca et al., 2005), we demonstrated 
that b5-ops-28 can translocate its C terminus across protein-free 
phospholipid liposomes as effi  ciently as across RMs. Therefore, 
we investigated whether the extended constructs that retain the 
ability to posttranslationally translocate into RMs were also 
competent for transmembrane insertion into pure lipid vesicles 
prepared by the extrusion of a mixture of bovine liver phospha-
tidylcholine (PC)/phosphatidylethanolamine or PC alone (Fig. 
4 A). Insertion into RMs was again assessed by glycosylation of 
the full-length protein (Fig. 4 A, top) and PF recovery (Fig. 4 A, 
bottom). In the case of liposomes, translocation of the C termi-
nus cannot be assayed by glycosylation but is revealed by the 
Figure 3.  Extended C-terminal domains of b5 constructs are translocated 
across the ER membrane of yeast mutants defective in translocon function. 
Wild-type yeast cells (lanes 1 and 2) or yeast cells harboring the sec61-3 
mutation transformed with the indicated b5 construct were incubated in 
low glucose medium for 1 h at 38°C and were 
35S labeled for 5 min at the 
same temperature. The cells were lysed and subjected to immunoprecipita-
tion with antiopsin antibody (top) or CPY antiserum (bottom). The immuno-
precipitates were divided in two, and one part was digested with EndoH 
before SDS-PAGE analysis as indicated. Asterisks and boxes indicate the 
glycosylated and nonglycosylated products, respectively.
Figure 4.  Posttranslational translocation of extended 
lumenal domains of b5 constructs occurs across ER 
  microsomes and protein-free liposomes with equal 
  efﬁ  ciency. (A) Posttranslational translocation reactions 
were performed with PC or PC/phosphatidylethanol-
amine (PE; 4:1 ratio) liposomes, with RMs at equivalent 
phospholipid concentration (0.7 μg phospholipids/μl) 
or without added vesicles as indicated. The total 
  number of charged amino acids and the net charge of 
the lumenal sequence are reported in parentheses 
above the lanes. Asterisks and boxes indicate the gly-
cosylated and nonglycosylated products, respectively. 
(B) Time course of translocation into RMs of b5-ops-28 
and -85 monitored by glycosylation.UNASSISTED TRANSLOCATION ACROSS LIPID BILAYERS • BRAMBILLASCA ET AL. 771
protease protection assay (Fig. 4 A; nonglycosylated PFs are 
  indicated by boxes in the bottom panel). Quite remarkably, all 
C-terminal domains capable of posttranslational translocation 
across RMs were translocated equally well across protein-free 
vesicles independently of length, sequence, and charge, and this 
was true even for the highly charged 85 residues of b5-ops-85 
(Fig. 4 A, lanes 13–15). As expected, the 104- and 125-residue–
long C-terminal tails were not observed to insert into protein-
free liposomes (Fig. S1 B).
Although b5-ops-85 inserts equally well into RMs and 
  liposomes, the extent of its translocation into both of these vesi-
cles was less than that of the parent construct b5-ops-28. This 
lower effi  ciency might be the result of either heterogeneity in 
the translocation competence of the longer construct such that 
only a fraction of molecules can insert or a reduced transloca-
tion rate of equivalent b5-ops-85 molecules. As shown in the 
time course experiment in Fig. 4 B, the proportion of glycosyl-
ated molecules increased linearly with time for both b5-ops-85 
and -28 during a period of 90 min, suggesting that in vitro–
translated b5-ops-85 constitutes a homogeneous population of 
slowly translocating molecules.
Role of TMD in TA protein translocation
Although b5 effi  ciently translocates its C terminus across the 
bilayer without assistance from ER proteins, other TA proteins, 
like Syb2, require one or more proteinaceous components of the 
ER for their integration (High and Abell, 2004). Because the 
protein-independent mechanism seems to be quite permissive 
with regard to the C-terminal sequence to be translocated, we 
investigated the role of the cytosolic and TMD in determining 
the requirements for TA protein insertion. We excluded the in-
volvement of b5’s cytosolic N-terminal domain by replacing 
this region with GFP in the b5-opsin-85 construct and observ-
ing that the resulting protein was still able to effi  ciently translo-
cate across pure lipid liposomes (Fig. S2, available at http://www.
jcb.org/cgi/content/full/jcb.200608101/DC1). Therefore, we fo-
cused on the TMD, replacing the core of b5’s TMD with the one 
of Syb2 (b5-Syb2-ops-28; Fig. 1 e). As shown in Fig. 5 A, the 
new construct was as effi  ciently glycosylated and translocated 
across posttranslationally added RMs as the parent construct 
b5-ops-28. However, different from b5-ops-28, the construct 
with Syb2’s TMD was unable to translocate its C terminus 
across protein-free liposomes (Fig. 5 A, bottom). b5-Syb2-ops-28, 
in contrast to the parent construct, generated two background 
bands after PK digestion in the absence of vesicles, which 
comigrated with the glycosylated and nonglycosylated PF (Fig. 
5 A, lane 4); as can be seen in Fig. 5 A (lane 6), the intensity of 
the PF bands obtained after incubation with PC liposomes was 
similar to that of the background bands.
We next asked whether the different behaviors of the 
two recombinant proteins was caused by a specifi  c amino 
acid sequence or, instead, was caused by differences in the 
Figure 5.  TMDs with increased hydrophobicity require a proteinaceous component of the ER for their insertion. (A and B) Co- or posttranslational transloca-
tions were performed with the indicated constructs, without added vesicles, or with RMs or PC liposomes (both at 0.7 μg phospholipids/μl). (A) Background 
bands generated after PK treatment in the absence of membranes are indicated with arrows (lanes 4 and 7). (B) Detergent controls for b5-Syb2mut-ops28 
and b5-scrambled-ops-28 are shown (lanes 7 and 13). For the other constructs, detergent controls are shown in Fig. S1 A (available at http://www.jcb.
org/cgi/content/full/jcb.200608101/DC1). (C) Analysis of RMs treated with different amounts of trypsin by immunoblotting. Digestion of the cytosolic re-
gion of ribophorin I results in a lower Mr band (arrows), which is revealed by the antiribophorin antibody raised against a lumenal epitope. (D) After diges-
tion of RMs with trypsin at the indicated concentrations, equal aliquots of the treated vesicles were incubated with the indicated in vitro–synthesized 
proteins. Background bands generated in the absence of vesicles are indicated with arrows. The percentage of translocation efﬁ  ciency, corrected for back-
ground and normalized to the efﬁ  ciency obtained in mock-treated RMs, is given below the lanes. Asterisks and boxes indicate the glycosylated and nongly-
cosylated products, respectively.JCB • VOLUME 175 • NUMBER 5 • 2006  772
physical/chemical characteristics of the two TMDs. As reported 
in Table I, the degree of the hydrophobicity of b5’s TMD is 
considerably lower than that of Syb2’s. To ascertain whether 
this difference in the hydrophobicity of the TMDs could ac-
count for the different translocation requirements of the two 
model proteins, we generated a construct with a TMD based on 
the one of b5 but modifi  ed by the substitution of four residues 
with more hydrophobic ones (b5-HH-ops-28; Fig. 1 e and Table I). 
As shown in Fig. 5 A, when tested in its ability to posttransla-
tionally translocate across RMs or liposomes, this construct 
showed the same behavior as the b5-Syb2-ops-28 chimera, in-
serting effi  ciently into RMs but not into protein-free vesicles.
To confi  rm that TMD hydrophobicity and not a specifi  c 
sequence is the principal parameter determining competence 
for unassisted insertion, we produced two further constructs: 
b5-scrambled-ops-28, in which the order of residues in b5’s 
TMD was changed, and b5-Syb2mut-ops-28, in which the TMD 
of Syb2 was mutated to become less hydrophobic (Table I). As 
shown in Fig. 5 B, both of these constructs were able to insert 
into protein-free liposomes (lanes 7 and 12), albeit with some-
what reduced effi  ciency compared with the parent construct 
b5-ops-28 (lane 3).
Previous studies have reported that Syb2 depends on a 
 microsomal trypsin-sensitive component for its insertion (Kutay 
et al., 1995; Kim et al., 1997; Abell et al., 2004). We asked whether 
Syb2’s TMD is suffi  cient to confer this trypsin sensitivity and, 
if so, whether the increased hydrophobicity is the basis for this 
effect. RMs were treated with increasing concentrations of tryp-
sin at 4°C to digest exposed proteins; effi  cacy of the treatment 
was verifi  ed by immunoblotting with antibodies against two ER 
integral membrane proteins, Sec61β and ribophorin I. As shown 
in Fig. 5 B, Sec61β was severely depleted already by treatment 
with 1 μg/ml trypsin, whereas ribophorin I was more resistant 
to the treatment and showed partial conversion to a shorter form 
lacking the cytosolic domain at higher trypsin concentration. 
The trypsin-treated or mock-treated RMs were tested for trans-
membrane integration of the parent b5-ops-28 and of the two 
constructs with modifi  ed TMD (Fig. 5 C). As expected, trypsin 
treatment had no effect on b5-ops-28’s ability to translocate its 
C terminus. In contrast, for the two constructs with more hydro-
phobic TMDs, even a mild trypsin digestion inactivated a 
  microsomal component that is required for insertion of the 
  constructs (Fig. 5 D, lanes 8–10 and 13–15).
PTB1B integrates into lipid bilayers 
by the same mechanism as b5
To investigate whether the ability to integrate into lipid bilay-
ers without assistance from membrane proteins is a peculiar-
ity of b5 or whether it is shared with other TA proteins, we 
analyzed the TMD sequence of 27 ER resident TA proteins 
(Table S3; available at http://www.jcb.org/cgi/content/full/
jcb.200608101/DC1), searching for unassisted translocation 
candidates on the basis of low TMD hydrophobicity. For anal-
ysis, we selected PTP1B, whose TMD is similar in length and 
hydrophobicity to the one of b5 (Table I). PTP1B is a pro-
totypic tyrosine phosphatase anchored to the ER membrane 
(Frangioni et al., 1992) and is involved in the regulation of 
numerous signaling events (Tonks, 2003). To adapt PTB1B to 
our assays, we appended the opsin epitope at its C terminus 
to obtain the PTP1B-ops-35 construct (Fig. 1 f and Table S1). 
As shown in Fig. 6 A, this PTP1B variant behaved exactly like 
b5-ops-28 in that (1) it posttranslationally inserted into RMs 
with the same effi  ciency as in cotranslational conditions, as 
judged by the appearance of a glycosylated form and by the 
recovery of a glycosylated PF, and (2) it inserted to the same 
extent into pure lipid liposomes, as shown by the presence of 
the nonglycosylated PF. Based on the ratio of glycosylated to 
nonglycosylated full-length protein, the effi  ciency of translo-
cation of PTP1B-ops-35’s C terminus was roughly the same as 
that of b5-ops-28 (Fig. 6 A, left).
Table I. Properties of TMDs of the constructs used in this study
Protein TMD sequence Mode of 
calculation
a
Number of residues 
in TMD
Hydrophobicity (GES scale)
Total Mean
c
b5 ...DSNSSW W  T  N  W  V  I  P  A  I  S  A  L  I  V  A  L  M   YR... TMD (1) 
TMD (2)
23 
17
27.1
28.9
1.18
1.67
Syb2 ...K M  M  I  I  L  G  V  I  C  A  I  I  L  I  I  I  I  V  Y  F   ST TMD (1) 
TMD (2)
22 
20
54.9
53.1
2.50
2.66
PTP1B ...KPFL V  N  M  C  V  A  T  V  L  T  A  G  A  Y   LCYR... TMD (1) 
TMD (2)
20 
14
29.1
18.7
1.46
1.34
b5-scrambled-ops-28 ...DSNSS W  W  A  S  A  I  I  A  T  M  I  P  L  L  V  N  V  W   YR… TMD (1) 
TMD (2)
23 
18
27.1
30.1
1.18
1.71
b5-HH-ops-28
b ...DSNS S  W  W  T  A  W  V  I  P  L  I  L  I  L  V  V  A  L  M   YR... TMD (1) 
TMD (2)
23 
19
37.9
42.2
1.65
2.22
b5-Syb2-ops-28 ...DSNSSW W  T  N  M  M  I  I  L  G  V  I  C  A  I  I  L  I  I  I  I  V   YFYR... TMD (1) 
TMD (2)
29 
21
49.6
48.4
1.71
2.3
b5-Syb2mut-ops-28
b ...DSNSSW W  T  N  M  M  G  I  L  G  V  G  C  A  G  I  L  —-V YFYR… TMD (1) 
TMD (2)
25 
17
30.9
29.7
1.24
1.75
aTMDs were deﬁ  ned either as the uncharged sequence close to the C terminus (sequence in between the charged residues, which are shown in bold; TMD (1)) or as the 
stretch with negative hydrophilicity according to the GES hydropathy scale (Engelman et al., 1986), computed with a window of seven residues (TMD (2)); indicated 
in italics. The TMD of b5-Syb2-ops-28 differs from the one of native Syb-2 (reported for comparison) in the ﬂ  anking sequences derived from b5.
bThe underlined characters in b5-HH-ops-28 and b5-Syb2mut-ops-28 indicate the residues that have been changed from the TMD of b5 and Syb2, respectively. In addition, 
the TMD of b5-HH-ops-28, which was derived from the rat protein, differs from the rabbit sequence (in b5-ops-28) by an I®V replacement at position 122 of the native 
polypeptide. This substitution has a negligible effect on the hydrophobicity of the TMD and no effect on translocation efﬁ  ciency (unpublished data).
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Figure 6.  Unassisted insertion of the TA protein PTP1B. (A) PTP1B engi-
neered with the opsin tag (Fig. 1 f) was tested for its ability to insert into 
RMs co- and posttranslationally or into PC liposomes (1.1 μg phospholip-
ids/μl in all cases). No PF was recovered in the absence of membranes 
or when detergent was present during PK digestion (right; lanes 4 and 8). 
The translocation behavior of b5-ops-28 was analyzed in parallel (left). 
(B) Effect of cholesterol on PTP1B translocation. Protein-free liposomes 
were prepared from PC–cholesterol mixtures as indicated and were tested 
for PTP1B-ops-35 insertion (1.3 μg phospholipids/μl) as in A. Asterisks and 
boxes indicate the glycosylated and nonglycosylated products, respectively.
To further compare the mechanisms of the transmembrane 
integration of b5 and PTP1B, we analyzed the effect of the cho-
lesterol content of liposomes on insertion effi  ciency (Fig. 6 B). 
Our previous work demonstrated that b5-ops-28 insertion is 
sharply inhibited by cholesterol levels only slightly higher than 
those normally found in the ER (Brambillasca et al., 2005). 
When in vitro–synthesized PTP1B-opsin-35 was incubated 
with liposomes containing increasing proportions of choles-
terol, translocation was supported only by cholesterol-poor 
ones, as is the case for b5-ops-28 (Brambillasca et al., 2005). 
Thus, the unassisted insertion pathway described for b5 can also 
be exploited by other TA proteins whose TMDs have a similar 
degree of hydrophobicity.
Energy requirements for posttranslational 
transmembrane integration
Although the unassisted translocation process itself must be 
nucleotide independent, energy consumption by chaperones 
could be necessary to maintain the translocation substrates in 
a competent conformation. Because this possibility appeared 
especially likely in the case of the constructs with extended 
C-terminal domains, we compared the energy requirements for 
the integration of the longest construct capable of unassisted 
translocation (b5-ops-85) with those of the parent construct 
b5-  ops-28. Nucleotides were depleted from translated samples by 
gel fi  ltration, and samples were further diluted into a buffer com-
patible with b5 integration to reduce the fi  nal ATP concentration 
to 3 nM. As shown in Fig. 7 A, severe nucleotide depletion had 
no effect on the effi  ciency of the translocation of b5-ops-28 
(compare lane 1 with 6) and, remarkably, had only a minor effect 
on that of the extended variant b5-ops-85 (compare lane 7 with 
12) into either RMs (top panels) or liposomes (bottom panels). 
Furthermore, the addition of ATP, GTP, or both to restore nucle-
otide levels to those of the reticulocyte lysate was without effect 
on the translocation of b5-ops-28 (Fig. 7 A, lanes 2–4) and was 
mildly stimulatory on b5-ops-85 (Fig. 7 A, lanes 8–10). These 
results indicate that unassisted translocation not only of b5’s 
C terminus but also of an extended polar domain appended to 
b5’s TMD has extremely low energy requirements.
At variance with b5, Syb2’s insertion is reported to be en-
ergy dependent (Kutay et al., 1995; Kim et al., 1997). We asked 
whether Syb2’s TMD alone is responsible for this effect by 
Figure 7.  Energy requirements for the transmembrane integration of b5 
constructs. (A) In vitro–synthesized b5-ops-28 and -85 were gel ﬁ  ltered and 
diluted in TB to obtain a ﬁ  nal ATP concentration of 3 nM (lanes 1 and 7). 
The diluted samples were incubated with RMs or PC liposomes (two top 
and two bottom panels, respectively), both at 0.15 μg phospholipids/μl, 
and were tested for insertion by protease protection. Where indicated, 
0.5 mM ATP, 0.1 mM GTP, or both were added (lanes 2–4 and 8–10). 
Samples not subjected to nucleoside triphosphate depletion were analyzed 
in parallel. (B) In vitro–synthesized b5-Syb2-ops-28 was subjected to gel ﬁ  l-
tration and diluted in TB to reach a ﬁ  nal ATP concentration of 5 nM during 
incubation with RMs (0.67 μg phospholipids/μl). ATP, GTP, or both were 
added where indicated as described for A. Samples not subjected to gel 
ﬁ  ltration were analyzed in parallel, and background signals were gener-
ated after PK digestion in the absence of membranes, as indicated with ar-
rows (lane 5). The percentage of translocation efﬁ  ciency normalized to the 
efﬁ   ciency obtained in mock-treated RMs and corrected for background 
and for the different input of gel-ﬁ  ltered and untreated samples is given be-
low the lanes. Asterisks and boxes indicate the glycosylated and nonglyco-
sylated products, respectively.JCB • VOLUME 175 • NUMBER 5 • 2006  774
  testing the transmembrane integration of the chimera b5-Syb2-
ops-28 after ATP depletion. As shown in Fig. 7 B, after nucleo-
tide depletion, insertion of the construct was severely reduced 
(lane 1). In agreement with Kutay et al. (1995) and Kim et al. 
(1997) but at variance with Abell et al. (2004), the readdition of 
ATP stimulated integration much more effectively than GTP. 
Thus, Syb2’s TMD confers to the chimera all of the insertion 
requirements of Syb2 itself.
Discussion
Membrane proteins generally integrate into the lipid bilayer 
  cotranslationally: during synthesis, the signal peptide or the fi  rst 
hydrophobic membrane-anchoring sequence to emerge from 
the ribosome is recognized by SRP, which delivers the nascent 
chain–ribosome complex to the translocation machinery of the 
ER membrane (Higy et al., 2004). The insertion pathway fol-
lowed by TA proteins represents an exception to this rule be-
cause members of this class of proteins lack an N-terminal 
signal sequence, and their membrane-anchoring sequence is 
too close to the C terminus to become cotranslationally avail-
able to SRP (Borgese et al., 2003). Given the important func-
tions of TA proteins in fundamental cellular processes, the 
molecular mechanisms underlying this posttranslational mode 
of transmembrane protein topogenesis are currently being stud-
ied in several laboratories.
The insertion pathway of a few TA proteins has been in-
vestigated in some detail, and important differences have been 
reported, as exemplifi  ed by Syb2 and b5. There is a general con-
sensus that Syb2 requires a proteinaceous component of the ER 
membrane and energy to associate with RMs (Kutay et al., 
1995; Kim et al., 1997, 1999; Abell et al., 2003, 2004), although 
there is disagreement regarding the nature of the involved 
  protein and of the energy donor (ATP or GTP). In contrast, b5 
integration occurs without assistance from any microsomal pro-
tein (Brambillasca et al., 2005) and appears to have very low 
energy requirements (Kim et al., 1997; Yabal et al., 2003).
In our previous work, we used a b5 variant carrying at its 
C terminus a 19-residue sequence derived from bovine opsin, 
which permitted us to monitor translocation by protection from 
proteolysis and/or glycosylation of the short translocated se-
quence (Brambillasca et al., 2005). The total length of the do-
main translocated without assistance, including the seven 
C-terminal residues of b5 itself, two linker residues, and the op-
sin sequence, was 28 residues. Two important questions were 
raised from this study: (1) what the maximum size is of the 
C-terminal polar domain that can be translocated without assis-
tance and (2) what the basis is for the reported differences in the 
insertion requirements for different TA proteins. In the present 
study, we address both of these issues.
As for the fi  rst question, we fi  nd that unexpectedly long 
sequences (up to 85 residues) appended to b5’s C terminus can 
be translocated across protein-free bilayers. Consistent with 
these in vitro observations, constructs with extended lumenal 
domains could effi  ciently transfer their C terminus into the ER 
lumen of yeast mutants defective in translocon function. The 
process of unassisted integration appeared to be relatively 
  insensitive to the nature of the sequence to be translocated. The 
three classes of sequences that were attached to b5’s C termi-
nus and that translocated without assistance by membrane pro-
teins in this study had different charge and different intracellular 
localizations when in their normal context: whereas the Hsp150 
and opsin sequence are exoplasmic, the VSVG sequence was 
derived from the cytosolic tail of the viral glycoprotein. The 
VSVG tag differed from the other two also in its net positive 
charge, arguing against any role of an electrochemical gradient 
in the translocation process. Furthermore, the b5-VSVG-33 
construct lacked the 19-residue opsin tag and the six C-terminal 
residues of b5, both of which are present in the other b5-
based constructs, excluding a role for these residues in 
unassisted translocation.
Although unassisted transmembrane integration was rela-
tively insensitive to the nature of sequences <100 residues ap-
pended to b5’s C terminus and was unchanged by substitution 
of the cytosolic domain, it was dramatically affected by the 
properties of the TMD, pinpointing the basis of the differing 
  requirements for transmembrane topogenesis of different TA 
proteins (the second question raised above). Substitution of b5’s 
TMD with the more hydrophobic one of Syb2 conferred on the 
chimera all of the properties reported for native Syb2: incapac-
ity to insert into liposomes, sharp inhibition of posttranslational 
integration by trypsin treatment of microsomes, and a require-
ment for energy (Kutay et al., 1995; Kim et al., 1997, 1999; 
Abell et al., 2004). These altered requirements for insertion 
were the result of the increased hydrophobicity of Syb2’s TMD 
and not of a specifi  c amino acid sequence because (1) an in-
crease in the hydrophobicity of b5’s TMD conferred by four 
amino acid substitutions was suffi  cient to completely block the 
unassisted translocation of even a short (28 residues) lumenal 
domain, (2) mutations that decreased the hydrophobicity of 
Syb2’s TMD conferred to the resulting construct the capability 
of unassisted insertion, and (3) scrambling the order of residues 
in b5’s TMD generated a construct that was still capable of in-
sertion into liposomes. In addition, we ruled out the possibility 
that the capacity for unassisted transmembrane integration is a 
peculiar feature of b5 by demonstrating the same capability of a 
nonrelated TA protein, PTP1B, which shares with b5 only the 
moderate hydrophobicity of its TMD.
Two other TA proteins whose membrane association has 
been investigated with binding assays, Nyv-1p (Steel et al., 
2002) and Sec61β (Abell et al., 2004), have requirements simi-
lar to those of Syb2, whereas another one, Bcl2, appears to be 
more like b5 (Kim et al., 1997). The behavior of these three TA 
proteins is predictable on the basis of the hydrophobicity of 
their TMDs (Table S3). Thus, TMD hydrophobicity appears to 
be a reliable predictor of whether or not assistance for trans-
membrane integration of a given TA protein is required.
Why should a more hydrophobic TMD preclude unas-
sisted translocation? A possible explanation is that newly syn-
thesized TA proteins with very hydrophobic TMDs require an 
ER protein and energy for delivery to the bilayer in a transloca-
tion-competent form rather than for the translocation step 
itself. It is known that the poor water solubility of hydrophobic 
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preformed lipid bilayers (Hunt et al., 1997; Reshetnyak et al., 
2006). TA proteins with TMDs of limited hydrophobicity may 
be endowed with a certain degree of water solubility, which 
would allow them to directly access the bilayer. In contrast, TA 
proteins with very hydrophobic TMDs are probably rapidly se-
questered into insoluble aggregates unless assisted by a chaper-
one, which might then require interaction with a cytosolically 
exposed ER protein to deliver the substrate to the bilayer. 
  According to one study, this chaperone function is fulfi  lled by 
SRP and SRP receptor, acting in concert via a novel posttrans-
lational mechanism (Abell et al., 2004). However, the observa-
tion supporting this conclusion is restricted to a small fraction 
of truncated Syb2 and Sec61β nascent chains immediately af-
ter their release with puromycin. With naturally terminated 
Syb2 polypeptide incubated for longer times with RMs, a re-
quirement for SRP receptor was not detected, and, in agree-
ment with our data, ATP but not GTP was necessary for 
association of the polypeptide to RM membranes (Kutay et al., 
1995). Thus, there appears to be more than one delivery path-
way of TA proteins to the ER.
The fi  nding reported here that a polar domain of nearly 
100 residues placed downstream of an appropriate TMD can be 
translocated across protein-free bilayers was quite unexpected. 
How can such large polar domains make it across the hydropho-
bic core of the lipid bilayer? The free energy released upon in-
sertion of the TMD (Moll and Thompson, 1994; Soekarjo et al., 
1996) could possibly provide the driving force to overcome the 
kinetic energy barrier to translocation of the polar domain. 
Thus, the TMD of b5 and of other TA proteins endowed with a 
similar capacity for unassisted insertion would function as 
nanosyringes, catalyzing the translocation of their own C-terminal 
polar domain, provided that the lipid bilayer to be crossed is 
suffi  ciently disordered and that the length of the polar domain is 
not excessive. Indeed, increasing bilayer order by the addition 
of cholesterol (Straume and Litman, 1987) results in sharp inhi-
bition of the process (Brambillasca et al., 2005; and this study); 
analogously, the constructs with long lumenal domains, for 
which the kinetic barrier to translocation is presumably higher, 
integrate more slowly than those with shorter ones. Above a 
certain length of the C-terminal domain, the free energy of in-
sertion of the TMD is presumably no longer suffi  cient to over-
come the activation energy barrier opposing translocation.
An important question concerns the folding status of the 
C-terminal domain that is translocated without assistance. 
Structural experiments on the N-terminal domain of opsin have 
revealed that it easily folds to yield a compact structure and 
that this folding also occurs in the absence of N-glycosylation 
(Yeagle et al., 2000). In contrast, the 19-residue repeat domain of 
Hsp150 appended in one or more copies to the Hsp constructs is 
unstructured (Jämsä et al., 1995). Thus, we expected that these 
two sequences might have different requirements for transloca-
tion because of a different folding status. Instead, the very low 
energy requirements for the b5-ops-85 construct argue against 
an active unfolding process occurring before translocation. It is 
possible that the opsin domain was not folded under our experi-
mental conditions or, alternatively, that it has suffi  cient confor-
mational fl  exibility to spontaneously oscillate   between folded 
and unfolded states. The problem of the conformation of the lu-
menal domain in the unassisted translocation pathway described 
here is the subject of ongoing investigation in our laboratory.
In addition to suggesting a mode of evolution of biomem-
branes, we believe that the results presented here have implica-
tions for contemporary membrane biogenesis and physiology. 
At present, we cannot rule out that TA proteins capable of trans-
membrane integration into protein-free liposomes in vitro are 
assisted in vivo by proteinaceous factors that accelerate their inser-
tion, as found for M13 and Pf3 phage coat proteins (Samuelson 
et al., 2000). However, the equal effi  ciency of insertion into 
RMs and protein-free liposomes of PTP1B and of all constructs 
based on b5’s TMDs as well as our previous demonstration of 
the absence in microsomal extracts of any protein stimulating 
b5-ops-28 translocation (Brambillasca et al., 2005) strongly 
suggest that the unassisted pathway characterized in vitro oc-
curs also in vivo. Unassisted insertion may be relevant not only 
for TA proteins and for some bacterial proteins (van Dalen and 
de Kruijff, 2004) but also for thylakoid membrane biogenesis 
(Di Cola et al., 2005). Furthermore, given its potential over-
lap with the cotranslational pathway, it could represent a sal-
vage mechanism for the insertion of some type II membrane 
proteins. It is well known that hydrophobicity is the principal 
parameter determining the affi  nity of signal sequences/anchors 
for SRP (Ng et al., 1996); thus, exactly those type II proteins 
that are more likely to escape from the cotranslational pathway 
would be better substrates for an unassisted salvage pathway. 
Finally, phenomena similar to the one reported here could un-
derlie voltage- (Qiu et al., 1996) and lipid (Bogdanov et al., 
2002)-dependent posttranslational rearrangements of mem-
brane proteins that involve the translocation of large domains 
across the bilayer. Unconventional mechanisms of membrane 
biogenesis like the one reported here are thus likely to be of 
general signifi  cance and are likely to attract increasing atten-
tion in the coming years.
Materials and methods
Recombinant plasmids
The constructs used in this study are illustrated in Fig. 1. Sequences of the 
TMDs and of the C-terminal lumenal domains are reported in Tables I and 
S1, respectively. All cDNAs for transcription/translation were cloned in the 
pGEM4 vector under the SP6 promoter and checked by sequencing. The 
recombinant plasmids were obtained by inserting cassettes of paired oligo-
nucleotides or of PCR-ampliﬁ  ed fragments into the parent plasmid b5-ops-28 
(called b5-Nglyc in a previous study [Brambillasca et al., 2005]) or into its 
derived extended constructs. The cDNA coding for PTP1B, which was a gift 
from J. Chernoff (Fox Chase Cancer Center, Philadelphia, PA; Chernoff et 
al., 1990), was subcloned into pGEM4 and modiﬁ   ed to contain the 
C-terminal opsin tag.
In vitro translocation assay
Transcription, translation in the reticulocyte lysate system (Promega), trans-
location reactions with RMs (a gift of R.S. Hegde, National Institute of 
Child Health and Human Development, Bethesda, MD) or liposomes pre-
pared by extrusion, digestions with PK, immunoprecipitation with antiopsin 
monoclonal antibody (a gift of P. Hargrave, University of Florida, Gaines-
ville, FL) used at 8 μg/ml or anti-VSVG polyclonal antibody used at 7 μg 
IgG/ml (Sigma-Aldrich), and SDS-PAGE analysis were performed as de-
scribed previously (Brambillasca et al., 2005). In each experiment, sam-
ples contained equal amounts of phospholipids, as speciﬁ  ed in the ﬁ  gure 
legends; phospholipid phosphorus in RMs was assayed according to Ames 
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  suspensions was assessed by measuring the recovery of 
3H-PC (GE Health-
care) included in trace amounts in the lipid mixtures before essication and 
extrusion. Incubations with vesicles were performed for 1 h unless speciﬁ  ed 
otherwise. Dried gels were either exposed to ﬁ  lm or to a phosphorimager 
screen (Storm; GE Healthcare). All quantiﬁ  cations were performed with the 
Storm phosphorimager using ImageQuant software (GE Healthcare). For 
comparisons of translocation efﬁ  ciency based on the amount of PF gener-
ated, intensity values of the PF bands were normalized to the amount of the 
total full-length product generated in the corresponding translation reac-
tion. In all ﬁ  gures, the numbers on the side of the panels indicate the posi-
tion and molecular mass (in kilodaltons) of size markers.
ATP depletion of in vitro–translated samples
90 μl of each translation reaction was gel ﬁ  ltered on Sephadex-25 ﬁ  ne 
columns (0.8 × 4 cm; Bio-Rad Laboratories) equilibrated in a buffer suit-
able for translocation (translocation buffer [TB]; 50 mM Hepes, pH 7.2, 
250 mM sorbitol, 70 mM KOAc, 5 mM K
+EGTA, 2.5 mM Mg(OAc)2, and 
2 mM DTT). 15 fractions of 90 μl were collected, and an aliquot of each 
was analyzed by SDS-PAGE to identify those with the maximum recovery 
of the radioactive protein. These were then assayed for ATP by the luciferin-
luciferase procedure as previously described (Yabal et al., 2003) and used 
in the translocation assays after appropriate dilution in TB.
Trypsin treatment of microsomal membranes
Four equivalents of RMs (see Walter and Blobel, 1983 for a deﬁ  nition) 
were incubated for 1 h at 4°C with increasing concentrations of trypsin in 
a ﬁ  nal volume of 50 μl trypsin buffer (50 mM triethanolamine–acetic acid, 
pH 7.5, 250 mM sucrose, and 1 mM DTT). Digestion was terminated by 
the addition of PMSF to 1 mM and aprotinin to 47 mTIU/μl for 15 min at 
4°C. Samples were then adjusted to 500 mM KOAc in a ﬁ  nal volume of 
200 μl, and RMs were sedimented at 63,000 rpm for 30 min in a rotor 
(TLA 100.3; Beckman Coulter), resuspended in 200 μl trypsin buffer, sedi-
mented again, and ﬁ  nally resuspended at 0.5 equivalents/μl in storage 
buffer (50 mM Hepes, pH 7.2, 250 mM sucrose, and 2 mM DTT). The ef-
fect of the trypsin treatment was assessed by Western blotting/ECL (Super-
Signal West Pico; Pierce Chemical Co.) with antiribophorin I (antibody 
RIL3; a gift from G. Kreibich, New York University School of Medicine, 
New York, NY; Wiest et al., 1997) and anti-Sec61β (provided by R.S. 
Hegde; Fons et al., 2003) antibodies.
Construction and metabolic labeling of yeast strains
The b5-ops constructs described in Fig. 1 (a and b) and in Tables I and S1 
were subcloned between the SUC2 promoter and the ADH1 terminator in 
the Escherichia coli yeast shuttle vector pFL26. The resulting plasmids cod-
ing for b5-ops-28, -47, -85, and -125 were designated pKTH5013, 
pKTH5126, pKTH5181, and pKTH5237, respectively. The control yeast 
strain H1689 was created by integrating pKTH5013 into the LEU locus of 
strain H245 (see Table S2 for yeast strains). The sec61-3 strains were cre-
ated by integrating the plasmids pKTH5103, pKTH5126, pKTH5181, and 
pKTH5237 into the LEU locus of the parental strain H257, generating 
strains H2270, H2237, H2240, and H2113, respectively. The sec61-2 
strains were created by transforming the same plasmids into H1693, creat-
ing strains H1698, H2148, H2151, and H2116, respectively (Table S2).
The aforementioned described yeast cells were grown in synthetic 
complete medium in full (2%) glucose at the permissive temperature (24°C). 
Expression of the b5 constructs and parallel inactivation of Sec61p were 
obtained by up-regulating the SUC promoter in 2% rafﬁ  nose (low glucose) 
medium at the restrictive temperature (38°C) for 1 h. Metabolic labeling of 
proteins with [
35S]methionine/cysteine (GE Healthcare), lysis, immunopre-
cipitation with antiopsin and anti-CPY antibodies, and endoglycosidase H 
digestion were performed as previously described (Yabal et al., 2003).
Online supplemental material
Fig. S1 shows the detergent controls for all of the b5 constructs and the 
lack of transmembrane integration of b5-hsp-104 and b5-ops-125 into 
liposomes. Fig. S2 shows the lack of effect of the substitution of b5’s cat-
alytic domain on unassisted translocation. Table S1 provides sequence 
information on the lumenal domains of all of the constructs analyzed in 
this study. Table S2 is a list of the yeast strains used for the in vivo stud-
ies, and Table S3 is a list of 27 TA proteins analyzed for TMD hydro-
phobicity. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200608101/DC1.
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